Skip to main content

Animations

MJFF Publications

6751 - 6760 of 8587 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2019
  • 2019
  • 2020
  • 2020
  • 2019
  • 2019
  • 2020
  • 2019
  • Summary Details
    RESTRICTED
    Title: Getting ahead in the race for a cure: How nonprofits are financing biomedical R&D
    Journal Name: Research Policy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.respol.2020.104032
    Best OA location URL:
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2020.05.014
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Recurrent neurologic symptoms complicating venom immunotherapy in a patient with systemic mastocytosis and severe Hymenoptera allergy
    Journal Name: The Journal of Allergy and Clinical Immunology: In Practice
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jaip.2019.07.040
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30396-5
    Best OA location URL:
    Citation Count: 110
  • Summary Details
    RESTRICTED
    Title: Wearable-based mobility monitoring: the long road ahead
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30033-8
    Best OA location URL:
    Citation Count: 28
  • Summary Details
    RESTRICTED
    Title: Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30108-3
    Best OA location URL:
    Citation Count: 117
  • Summary Details
    RESTRICTED
    Title: Movement disorders in 2019: from antibodies to lifestyle interventions
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30438-7
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Multiple sclerosis in 2019: predicting progression
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30441-7
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Developing therapies for Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30320-3
    Citation Count: 4
  • Summary Details
    OPEN
    Title: A cornerstone initiative for progress in Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30432-6
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.